| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb03694360a0fbedb5c99bd6ec37395c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2570-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2560-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-72 |
| filingDate |
2014-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a21c40e75b9729796a017ecfebe6024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7359bba745b50ec4191a69ca2925a548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80e1cb508f8bd601d5bdd95b60fab022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46717f59d7f019214013cb2921f00980
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91f6138cd82117c7de39dbd7e0af9079
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e129e9a4cae8e3aed086aa14bfe9a68c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6f3a6e30b63a8434ce842fe2a6666e9 |
| publicationDate |
2016-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2015009940-A |
| titleOfInvention |
TYPE 2 DIABETES BIOMARKERS AND THEIR USES. |
| abstract |
The present invention provides biomarkers, methods and kits for the diagnosis and prognosis of the development of glucose intolerance in an individual and the progression of diabetes in an individual, as well as methods for identifying a compound that can inhibit the development of glucose intolerance and / or type 2 diabetes; reduce or slow the progression of normal glucose tolerance to impaired fasting glycemia, glucose intolerance and / or diabetes; and / or that reduces or inhibits the development of complications associated with the disease in an individual, and methods to inhibit the development of glucose intolerance and / or type 2 diabetes; to reduce or slow the progression of normal glucose tolerance to impaired fasting blood glucose, glucose intolerance and / or diabetes; and / or to reduce or inhibit the development of complications associated with the disease in an individual. |
| priorityDate |
2013-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |